Bloomios, Inc. Provides Revenue Guidance for the Second Quarter of 2023
June 01, 2023 at 03:50 pm EDT
Share
Bloomios, Inc. provided revenue guidance for the second quarter of 2023. The company expected second quarter of 2023 revenues to exceed $3 million, up more than 137% from $1.3 million in the same year-ago period.
Bloomios, Inc. manufactures, markets, and distributes hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States, through its wholly owned subsidiary, Bloomios Private Label (BPL). BPL is engaged in the manufacturing, processing, sourcing and distribution of hemp-derived, nootropic and nutraceutical products to wholesalers and retailers. The Company manufactures hemp infused products ranging from human edibles, pet edibles, liquid consumables such as tinctures and shots, topicals, and smokable hemp. It provides support at each step from custom formulation, order fulfillment, and brand development. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages and pet treats. It offers its private-label and white-label customers a collections of customizable hemp products that includes over 80 products across seven categories in addition to custom formulation and manufacturing services.
BLOOMIOS, INC. 
